In vitro and in vivo, the EGFR pathway genes and the genes involved in cell-cycle were scrupulously regulated by METTL1-mediated m7G tRNA modification and thus promoted intrahepatic cholangiocarcinoma (ICC) progression (Dai et al., 2021). Here, EGFR is linked to intrahepatic cholangiocarcinoma.